ArticleFoods (Basel, Switzerland)2026
Evaluation of the Functional and Nutritional Properties of Alpha-Amylase-Modified Cassava Starch in Breadmaking.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alpha-Amylase-Modified Cassava Starch in the Presence of Calcium Lactate as a Sour Starch Substitute for Gluten-Free Breadmaking.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Few strategies have been developed to mimic and control the supramolecular degradations induced by spontaneous fermentation in sour cassava starch, which are partly responsible for its characteristic expansion capacity in breadmaking, and their effectiveness has remained limited. In this context, the objective of this study was to evaluate the effect of adding α-amylase on the functional and nutritional properties of cassava starch used in breadmaking. Cassava starch from the INIAP 651 variety was modified with different α-amylase dosages (0, 2, 4, 6, 8, and 9 U/g α-amylase for 20 min), followed by hydration and pre-gelatinization before baking. Determinations of the specific volume of the bread (SV), dough characterization by Mixolab, pasting properties using a rheometer, and nutritional properties were performed. The treatment with 6 U/g α-amylase showed the best functional properties, achieving the highest SV (4.28 mL/g), C3 (1.67 Nm), C4 (1.11 Nm), and peak viscosity (6550 mPa·s), as well as the lowest setback (1526 mPa·s). In contrast, the treatment with 9 U/g α-amylase exhibited the most favorable nutritional profile, with the lowest estimated glycemic index (51.25) and rapidly digestible starch (15.85 g/100 g). These results confirm that controlled α-amylase dosing modulates cassava starch functionality for breadmaking and glycemic control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.